Workflow
Precision BioSciences, Inc. (DTIL) Discusses ARCUS Platform Progress and ELIMINATE-B Clinical Trial Update for Chronic Hepatitis B Transcript

PresentationIt is now my pleasure to turn the call over to Naresh Tanna, Head of Investor Relations. The floor is yours.Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Precision BioSciences AASLD update call. [Operator Instructions]Naresh TannaChief of Staff to CEO & Head of Investor Relations Thank you, Tina. Good morning, everyone, and welcome to the Precision BioSciences 2025 AASLD business update. I am joined ...